Mergers & Acquisitions ·
On June 11, 2026, Lixte Biotechnology Holdings, Inc. entered into a merger agreement to acquire Nomad Transportable…
LIXTNomad Power Solutions, Inc.
On June 11, 2026, Lixte Biotechnology Holdings, Inc. entered into a merger agreement to acquire Nomad Transportable Power Systems, Inc. through a merger subsidiary. Consideration for Nomad shares includes up to 50,500 shares of Series D Convertible Preferred Stock (issue price $1,000 per share, convertible to 50,500,000 common shares at $1.00 per share) and up to 3,000,000 shares of common stock. Closing conditions include Lixte maintaining at least $16,500,000 in unrestricted cash, the appointment of John Travaglini as CEO of the merger sub and to the Board, and stockholder approval for the preferred stock conversion and authorized share increase. Unaccredited Nomad stockholders will receive cash based on a 60-day volume-weighted average price. The company operates in the biotechnology industry.